Immediate Impact
3 standout
Citing Papers
Gastric cancer treatment: recent progress and future perspectives
2023 Standout
Biomarker-targeted therapies for advanced-stage gastric and gastro-oesophageal junction cancers: an emerging paradigm
2021 Standout
Works of F. Lordick being referenced
LBA-06 IMAB362: a novel immunotherapeutic antibody targeting the tight-junction protein component CLAUDIN18.2 in gastric cancer
2016
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| F. Lordick | 9 | 3 | 8 | 7 | 4 | 25 | |
| Massimo Castoldi | 18 | 5 | 9 | 8 | 5 | 31 | |
| Anne Dusart | 12 | 11 | 6 | 4 | 27 | ||
| Caterina Vita | 6 | 6 | 7 | 4 | 29 | ||
| Yanping Cai | 9 | 8 | 3 | 4 | 22 | ||
| Indrani Sardesai | 10 | 3 | 8 | 2 | 4 | 23 | |
| Joydeep Grover | 16 | 4 | 14 | 4 | 3 | 29 | |
| Ignazio Cusmano | 8 | 2 | 6 | 2 | 4 | 18 | |
| Zachary Girvin | 8 | 8 | 5 | 4 | 18 | ||
| A Yıldırım | 17 | 1 | 6 | 13 | 3 | 23 | |
| A Kardos | 6 | 2 | 4 | 3 | 4 | 16 |
All Works
Loading papers...